Showing results (1361-1370 of 1,767) with videos related to

Sort By:
Pageof 177
Journal of Personalized Medicine|January 22, 2024
User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry PatientsCatherine R Virelli, Mahbod Ebrahimi, Ayeshah G Mohiuddin, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|June 9, 2026
Barriers to Hearing Health Care in the Northern US: A Comparison of Rural and Urban MinnesotansCatherine L Kennedy, Nivedita Sabarinathan, August Richter, et al.
Obstetrics and Gynecology|February 1, 1980
Amniotic fluid optical density and neonatal respiratory outcomeC L Cetrulo, A J Sbarra, R J Selvaraj, et al.
Critical Reviews in Toxicology|August 27, 2004
The toxicology of perfluorooctanoateGerald L Kennedy, John L Butenhoff, Geary W Olsen, et al.
American Journal of Medical Genetics|February 16, 1996
Direct detection of expanded trinucleotide repeats using PCR and DNA hybridization techniquesA Petronis, H H Heng, Y Tatuch, et al.
The Pharmacogenomics Journal|July 12, 2017
Genome-wide association studies of placebo and duloxetine response in major depressive disorderM Maciukiewicz, V S Marshe, A K Tiwari, et al.
Molecular Psychiatry|October 22, 2003
Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorderV L Misener, P Luca, O Azeke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosisPing L Zhang, Phillip K Pellitteri, Amy Law, et al.
Pharmacogenomics|November 12, 2015
Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorderMalgorzata Maciukiewicz, Victoria S Marshe, Arun K Tiwari, et al.
Journal of Psychopharmacology (Oxford, England)|November 4, 2020
Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophreniaFarhana Islam, Malgorzata Maciukiewicz, Natalie Freeman, et al.
Pageof 177